Dallah Healthcare Company
Dallah Healthcare Company scores highest on Earnings (71) and lowest on Nitro (31). Its PosiPenta is 47.65 out of 100, around the middle of similar companies.
Compared with similar companies in the Healthcare sector in Saudi Arabia.
The five pillars
Details
PPrice
| P/E ratio | 16.62 |
| P/B ratio | 1.77 |
EEarnings
| Trailing EPS | ₹91.40 |
| Forward EPS | ₹129.62 |
NNitro
| Price | 1519.04 |
| 52-week high | 3284.93 |
| 52-week low | 1462.08 |
| Fall from 52-week high | 53.8% |
TTorque
| Return on equity (ROE) | 10.31% |
| Debt-to-equity | 1.02 |
AAnchor
| Beta (price swings) | -0.47 |
| Market cap | ₹18,515 Cr |
| Insider holding | 51.96% |
| Dividend yield | 2.62% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Dallah Healthcare Company's PosiPenta score?
Dallah Healthcare Company's PosiPenta is 47.65 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Which PosiPenta pillar is strongest for Dallah Healthcare Company?
Earnings (growth), with a score of 71 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Dallah Healthcare Company?
Nitro (momentum), with a score of 31 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.